Please login to the form below

Not currently logged in
Email:
Password:

Sosei appoints CFO

Andrew Oakley joins the Tokyo-based pharma firm

Sosei Andrew OakleyAndrew Oakley has joined Tokyo-based pharmaceutical firm Sosei as chief financial officer, succeeding Hidetoshi Torami.

Oakley brings a varied corporate finance career to the firm, most recently having served as chief financial officer of Vectura Group.

Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

Peter Bains, chief executive officer of Sosei, said: “Andrew brings a wealth of global corporate finance experience, expertise and leadership with a particularly strong focus in the biotechnology sector.

“I am delighted to welcome him to Sosei as our new chief financial officer and look forward to working with Andrew in the coming years as we seek to build Sosei into a global presence.”

31st January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics